Argosy Research (3217) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Argosy Research TWD 300, price TWD 130, upside +131.1%, quality 84 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Argosy Research for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range 48.10 TWD – 195.07 TWD · fair‑value band 179.26 TWD – 377.97 TWD · the 130.00 TWD price screens below the 300.36 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow Argosy Research in your weekly email
Every Wednesday you see whether Argosy Research is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Argosy Research Inc. manufactures and sells of electronic components and connectors in Asia, the United States, and internationally. It offers LPDDR5 CAMM2; DDR SODIMM; DDR DIMM; TYPE-C; PCI EXPRESS; M.2 / NGFF; LVDS; RF; SPI Flash; and Customized Connectors. It also provides fine-pitch, high pin-count, SMT-type, and high-frequency connectors.
Show more
Argosy Research Inc. manufactures and sells of electronic components and connectors in Asia, the United States, and internationally. It offers LPDDR5 CAMM2; DDR SODIMM; DDR DIMM; TYPE-C; PCI EXPRESS; M.2 / NGFF; LVDS; RF; SPI Flash; and Customized Connectors. It also provides fine-pitch, high pin-count, SMT-type, and high-frequency connectors. In addition, it offers ODM and OEM development services. Further, it offers DDR SODIMM; M.2; DDR DIMM; USB Type-C; and micro stamping parts. Argosy Research Inc. was founded in 1987 and is headquartered in Hsinchu City, Taiwan.
Stock analysis
Argosy Research (3217) currently trades at 130.00 TWD, while our model-based Fair Value estimate is 300.36 TWD, implying the stock looks roughly 56.7% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 306.02 TWD per share, and 22 of the 26 models we run sit above the 130.00 TWD price.
Bear case: the Asset-Based group reads lowest at 34.78 TWD, and 4 of the 26 models stay below the price. Evidence for this calculation is high.
Scenario range: 179.26 TWD (bear) to 377.97 TWD (bull), the price of 130.00 TWD sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 84/100 (high quality), in the Technology sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Argosy Research reported revenue of 4.1B TWD in FY2025 versus 3.0B TWD in FY2021, a compound +8.3%/yr. Reported net income was 1.1B TWD in FY2025, compounding +15.6%/yr from FY2021.
Key figures
Market cap 11.7B TWD (≈ $368M) · P/E ratio 10.3 · P/S ratio 2.84 · EPS (TTM) 12.61 TWD · Dividend yield 6.4% · Net margin 27.6% · Return on equity 25.8% · Return on assets (EBIT) 17.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 58 out of 100 (low confidence).
What moves the price
The share trades about 33% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at −65% fair-value upside, at 131%, 3217 screens cheaper than that median.
Fair Value models
Bear 179.26 TWDFair Value 300.36 TWDBull 377.97 TWD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (9.22 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.90/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+19.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+16.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.8%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.0%
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+19.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+12.8%
Dividend (yield on the price)6.4%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.29% → 31%
2025 sits 57% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+2.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about +1.1% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electronic Components · 660 stocks
Beats the industry median on 10/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score84 · Top 25%
Fair Value upside+131% · Top 25%
Profitability
Return on equity (TTM)26% · Top 25%
Return on assets12% · Top 25%
Net margin (TTM)28% · Top 25%
Operating margin (TTM)28% · Top 25%
Growth and dividend
Revenue growth−10% · Bottom 25%
Dividend yield (TTM)6.4% · Top 25%
Valuation Multiplesvs Electronic Components median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Argosy Research Fair Value". https://www.fairvalue-calculator.com/stock/3217
Frequently asked questions
Is Argosy Research (3217) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of 300.36 TWD versus a price of 130.00 TWD, about +131% upside (undervalued).
What is the fair value of 3217?
Our model-based fair value for Argosy Research is 300.36 TWD (as of Sep 23, 2026), built from audited fundamentals. The current price: 130.00 TWD.
What is the quality score of 3217?
Argosy Research has a Quality Score of 84/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Argosy Research (3217)?
Our model-based price target is the fair value of 300.36 TWD (as of Sep 23, 2026) from 26 valuation models. Cautious scenario 179.26 TWD, optimistic scenario 377.97 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Argosy Research stock forecast for 2026?
Our models put fair value at 300.36 TWD, about +131% upside versus a price of 130.00 TWD (undervalued). Cautious scenario 179.26 TWD, optimistic scenario 377.97 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Argosy Research (3217)?
Argosy Research reported trailing-twelve-month revenue of about 4.1B TWD (latest available figure, as of Sep 23, 2026).
Does Argosy Research pay a dividend?
Argosy Research currently shows a dividend yield of about 6.40% relative to its recent price (as of Sep 23, 2026).
What growth is priced into Argosy Research (3217)?
For today's price to be fair in a discounted-cash-flow model, Argosy Research would have to grow free cash flow by +2.7 % per year for five years (discount rate 12.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +9.8 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of 3217 use?
Our models discount Argosy Research at 12.7 %: a base by market capitalisation (small), damped by beta 1.31, country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Argosy Research that is +2.7 % per year a year over ten years, using the same discount rate (12.7 %) and the same formula as our fair value.
How much growth has Argosy Research (3217) delivered so far?
Over the past 5 years revenue at Argosy Research grew +9.8 % a year. The price currently implies +2.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Argosy Research (3217) growing?
The median revenue growth in the sector is +8.3 % a year. That is the yardstick for the growth priced into Argosy Research (+2.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Argosy Research (3217)?
The free-cash-flow yield on the price is 8.91 %: that much free cash flow Argosy Research produces per unit of market value. When it exceeds the discount rate of our models (12.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Argosy Research (3217)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Argosy Research it is 300.36 TWD per share (as of Sep 23, 2026), against a price of 130.00 TWD. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Argosy Research stock overvalued or undervalued in 2026?
As of Sep 23, 2026, 3217 trades below its calculated fair value: price 130.00 TWD, fair value 300.36 TWD, a gap of about +131% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 3217?
No. The price is what the market pays today (130.00 TWD); the fair value is what the company's own numbers justify (300.36 TWD). For Argosy Research the two are 170.36 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Argosy Research worth?
The market values Argosy Research at about 11.7B TWD (market capitalisation, as of Sep 23, 2026). Per share that is 130.00 TWD; our models calculate a fair value of 300.36 TWD per share.
What do the bullish and bearish scenarios say about 3217?
Our models span a range for Argosy Research: cautious scenario 179.26 TWD, base 300.36 TWD, optimistic 377.97 TWD per share (as of Sep 23, 2026, price 130.00 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 3217?
Argosy Research trades at a price-to-earnings ratio of 10.3 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 300.36 TWD is built from several models across several years. Other multiples: P/B 2.5, P/S 2.9, EV/EBITDA 7.2.
How solid is the balance sheet of Argosy Research (3217)?
Balance-sheet figures for Argosy Research (as of Sep 23, 2026): return on equity 25.8%. They feed the Quality Score of 84/100, which measures business quality independently of the share price.
How far is 3217 from its 52-week high?
Argosy Research trades at 130.00 TWD, about 33% below its 52-week high of 195.07 TWD and 2% above the low of 127.00 TWD (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 300.36 TWD is for.
Which stocks are comparable to Argosy Research?
From the same area (Technology) we also value Amphenol Corporation, Delta Electronics, Inc, Corning Incorporated, Luxshare Precision Industry Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Argosy Research stock attractive at the current price?
The data as of Sep 23, 2026: price 130.00 TWD, calculated fair value 300.36 TWD (+131%), Quality Score 84/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 3217 calculated?
We run Argosy Research through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 300.36 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Argosy Research currently trades 131 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Argosy Research (3217)?
The closing price on Sep 23, 2026 was 130.00 TWD. Our model-based fair value is 300.36 TWD, about +131% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Argosy Research right now?
The rarer combination: high quality (84/100) AND below fair value. That earns a closer look rather than a quick verdict. The price is below even our cautious bear case (179.26 TWD). The market is more pessimistic than our downside scenario. A fairly wide model range (179.26 TWD to 377.97 TWD) leaves room in how you read the outcome.
Key figures of Argosy Research
How large is the market capitalisation of Argosy Research (3217)?
The market capitalisation of Argosy Research is 11.7B TWD (≈ $368M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Argosy Research (3217)?
The price-to-sales ratio of Argosy Research is 2.84 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Argosy Research (3217)?
Earnings per share at Argosy Research are 12.61 TWD (price ÷ EPS = P/E 10.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Argosy Research (3217)?
The dividend yield of Argosy Research is 6.4% (payout 66.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Argosy Research (3217)?
The net margin of Argosy Research is 27.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Argosy Research (3217)?
The return on equity (ROE) of Argosy Research is 25.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Argosy Research (3217)?
On an EBIT basis the return on assets of Argosy Research is 17.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Argosy Research (3217)?
The operating margin of Argosy Research is 28.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Argosy Research (3217)?
Revenue at Argosy Research is growing −10.1% versus a year earlier (3y avg +16.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Argosy Research (3217)?
Earnings per share at Argosy Research are growing +3.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Argosy Research (3217) hold?
Argosy Research holds more cash than debt, 1.4B TWD net (fiscal year 2023). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Argosy Research in the live analysis
One click puts Argosy Research on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
